Validation of Walking and Remembering Test
A Study to Assess The Balance Using Remote Access Method - Walking and Remembering Test Validation
In this study, the usability of the Walking and Remembering Test will be examined using the remote interview method. The study will be carried out with a single group. First, the WART test will be performed face-to-face at Marmara University Biomechanics Laboratory. The second evaluation will be carried out using a remote method. From the participants;
- He/she will first be asked to walk freely within a line that is 8 meters long and 19 cm wide. Later;
- He will be asked to walk once at average speed and three times as fast as possible in the same line. Later;
- The participant is given a Counting Test. This test includes number sequences from 4 digits to 9 digits. Participants are told these number strings and asked to repeat them with the same speed and tone of voice. The longest sequence of numbers is recorded. Later;
- The participant is walked on the same line again and asked to repeat the longest number sequence he remembers and the test is completed. Cognitive performance with the counting test reflects walking speed during 4 walks, and the number of incorrect steps reflects walking performance.
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Contact
Study Contact
- Name: Emre Şenocak, PhD
- Phone Number: +90 553 569 56 92
- Email: emre.senocak@windowslive.com
Study Locations
-
-
-
İstanbul, Turkey, 34840
- Marmara University, Department of Physiotherapy and Rehabilitation, Biomechanics and Performance Analysis Laboratory
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Having any known psychological, vestibular and neurological diseases,
- No major or minor hip, knee or ankle injuries,
- Not showing osteoarticular or muscle traumas that prevent upright posture and ambulation,
- Not taking medications that affect posture, such as vestibular apparatus sedatives, antidepressants or anxiolytics,
- Not complaining of dizziness or vertigo,
- Being between the ages of 18-30.
Exclusion Criteria:
- Individuals with untreated visual impairment,
- Epilepsy, postural dizziness or hypotension,
- Individuals with dependent ambulation,
- Individuals with any disease that affects balance,
- Those with cancer or fibromyalgia.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: Walking and Remembering Group
Only Walking and Remembering Test will be applied to the group.
|
Only Walking and Remembering Test will be applied to the group.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Walking and Remembering Test (WART)
Time Frame: Baseline of the study (Face-to-Face)
|
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance.
In the test, walking and memory are observed independently and under dual-task conditions.
|
Baseline of the study (Face-to-Face)
|
|
Walking and Remembering Test (WART)
Time Frame: First day after the Baseline Assessment (Remote Assessment)
|
WART is a clinical measure of dual-task ability involving individual and simultaneous motor and cognitive task performance.
In the test, walking and memory are observed independently and under dual-task conditions.
|
First day after the Baseline Assessment (Remote Assessment)
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Demographic Data Form
Time Frame: Baseline of the study
|
This form was created by researchers and it consist of personal informations such as gender, dominant extremity, history of sport, age, body mass index
|
Baseline of the study
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Study Chair: Aysel Yildiz Ozer, Professor, Marmara University
- Study Chair: Semra Oğuz, Associate Professor, Marmara University
- Study Chair: Gökçe Kartal, MSc, Marmara University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 25.07.2024/112
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.